J Exp Med. 1992 Nov 1;176(5):1453-7.

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T.

Source

Ludwig Institute for Cancer Research, Brussels Branch, Belgium.

Abstract

We have reported the identification of human gene MAGE-1, which directs the expression of an antigen recognized on a melanoma by autologous cytolytic T lymphocytes (CTL). We show here that CTL directed against this antigen, which was named MZ2-E, recognize a nonapeptide encoded by the third exon of gene MAGE-1. The CTL also recognize this peptide when it is presented by mouse cells transfected with an HLA-A1 gene, confirming the association of antigen MZ2-E with the HLA-A1 molecule. Other members of the MAGE gene family do not code for the same peptide, suggesting that only MAGE-1 produces the antigen recognized by the anti-MZ2-E CTL. Our results open the possibility of immunizing HLA-A1 patients whose tumor expresses MAGE-1 either with the antigenic peptide or with autologous antigen-presenting cells pulsed with the peptide.

PMID:: 1402688; [PubMed - indexed for MEDLINE]
PMCID:: PMC2119413

Free PMC Article

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Melanoma - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. [J Exp Med. 1994]
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.
Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T. J Exp Med. 1994 Mar 1; 179(3):921-30.
Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. [Eur J Immunol. 1994]
Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.
van der Bruggen P, Szikora JP, Boël P, Wildmann C, Somville M, Sensi M, Boon T. Eur J Immunol. 1994 Sep; 24(9):2134-40.
Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1. [Dermatology. 1993]
Perspectives for immunization of HLA-A1 patients carrying a malignant melanoma expressing gene MAGE-1.
Marchand M, Brasseur F, van der Bruggen P, Coulie P, Boon T. Dermatology. 1993; 186(4):278-80.
Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide. [Cancer Immunol Immunother. 1994]
Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide.
Salgaller ML, Weber JS, Koenig S, Yannelli JR, Rosenberg SA. Cancer Immunol Immunother. 1994 Aug; 39(2):105-16.
Review Genes coding for tumor antigens recognized by human cytolytic T lymphocytes. [J Immunother Emphasis Tumor Im...]
Review Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.
Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T. J Immunother Emphasis Tumor Immunol. 1993 Aug; 14(2):104-9.

See reviews... See all...

Cited by 49 PubMed Central articles

SST-2 tumor inoculation is a useful model for studying the anti-tumor immune response in SHR rats. [Environ Health Prev Med. 2003]
SST-2 tumor inoculation is a useful model for studying the anti-tumor immune response in SHR rats.
Nishio N, Oishi K, Machida K. Environ Health Prev Med. 2003 Mar; 8(1):1-5.
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. [PLoS One. 2010]
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response.
Mroz P, Szokalska A, Wu MX, Hamblin MR. PLoS One. 2010 Dec 14; 5(12):e15194. Epub 2010 Dec 14.
Review Stimulation of anti-tumor immunity by photodynamic therapy. [Expert Rev Clin Immunol. 2011]
Review Stimulation of anti-tumor immunity by photodynamic therapy.
Mroz P, Hashmi JT, Huang YY, Lange N, Hamblin MR. Expert Rev Clin Immunol. 2011 Jan; 7(1):75-91.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
OMIM (calculated)
Online Mendelian Inheritance in Man (OMIM) records that include the current articles as references in the light bulb links within or in the citations at the end of the OMIM record. The references available through the light bulb link are collected using the PubMed related articles algorithm to identify records with similar terminology to the OMIM record.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic ...
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.
J Exp Med. 1992 Nov 1 ;176(5):1453-7.

PubMed
Experimental meditation.
Experimental meditation.
J Nerv Ment Dis. 1963 Apr ;136:329-43.

PubMed
Autosomal dominant 'Mediterranean fever' in a Finnish family.
Autosomal dominant 'Mediterranean fever' in a Finnish family.
J Intern Med. 1992 Oct ;232(4):365-9.

PubMed
The token test: A sensitive test to detect receptive disturbances in aphasics.
The token test: A sensitive test to detect receptive disturbances in aphasics.
Brain. 1962 Dec ;85:665-78.

PubMed
Adverse response to vital bleaching.
Adverse response to vital bleaching.
J Endod. 1992 Jul ;18(7):351-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: